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ABSTRACT  
Background: Antibiotic drug overuse and inappropriate antibiotic drug selection are associated with increased drug resistance among 
respiratory pathogens (most notably, Streptococcus pneumoniae), possible progression to chronic disease, and increased treatment costs.[1] The 
selection of an antibiotic for prophylaxis should be based on known or likely target pathogens, for a short duration of time.  
Objective: To evaluate Rational use of antibiotics in Paediatric patients suffering from Respiratory tract    infections.  
Method: It was Prospective, observational study conducted by random selection of patients. Based on diagnosis, the study population was 
categorized into 2 groups: Upper respiratory tract infections and Lower respiratory tract infections. The study population was interviewed 
after obtaining written informed consent for information like demographics, diagnosis, treatment and antibiotics prescribed.  
Results and Discussion: In our study population, it was observed that male patient (74%) were higher than female patients (26%). Total 
number of antibiotics prescribed during the study period is 83. Most commonly prescribed antibiotic was Augmentin (Amoxicilli n +Clavulanic 
acid) of dose (450mg IV BD) which is the combination drug, i.e, more effective than individual antibiotic drugs. 
Conclusion: In the present study it is observed that 4-different classes of antibiotics-Pencillins,Cephalosporins,Macrolides and 
Aminoglycosides were prescribed and used for different Respiratory diseases.The percentage of average antibiotic utilization is highest in 
Lower Respiratory Tract Infection with (55.22%).Mostly used Antibiotic in males for both LRTI and URTI is Augmentin with the percentage of 
(52%) and (80%) respectively.Where as in females it is observed that in both LRTI and URTI mostly used Antibiotic is Augmentin with 
percentage of (38.8%) and( 80%) respectively.Overall Second mostly used antibiotic is Ceftriaxone. 
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INTRODUCTION 
Respiratory tract infection refers to any of a number of 
infectious diseases involving the respiratory tract. Upper 
respiratory tract includes Nasal cavity, pharynx, Larynx. 
Lower respiratory tract includes Trachea, Bronchi, 
bronchioles and lungs. Antibiotics are commonly prescribed 
for RTI in adults and children in primary care. 
 Upper respiratory tract infections: Cold and flu, Tonsillitis, 
Pharyngitis, Otitis media, Influenza, Acute sinusitis.Lower 
respiratory tract infections: Tracheitis, Laryngitis, 
Epiglottitis, Bronchiolitis, Pneumonia.[2,3] 
 
Rational Use of Antibiotics 
The rational use of medicines is defined as “patients receive 
medications appropriate to their clinical needs, in doses that 
meet their requirements, for an adequate period of time, and 
at the lowest cost to them and their country”. 
Guidelines: 
 Evaluate the infection by clinical diagnosis: The clinician 
should always consider whether or not antibiotic 
therapy is even necessary for the patient by weighing the 
benefits (efficacy, rapid recovery and comfort of patient) 
Hussaini et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2020; 10(3):36-41 
ISSN: 2250-1177                                                                                  [37]                                                                                 CODEN (USA): JDDTAO 
 
 
against the risks (antibiotic resistance, adverse effects) 
and costs of treatment. 
 Select an appropriate antibiotic therapy: A clinician 
should decide whether to direct a patient to a definitive 
therapy or an empirical therapy or a prophylactic 
therapy 
 Definitive therapy:  
- When the etiology of the infection is known, the clinician 
should proceed with definitive therapy. 
- Empiric the clinician should confirm the bacterial infection  
- A negative microbiology test report can make it easier for 
the clinician to refuse unnecessary prescription of antibiotic. 
 Empirical therapy:  
- Clinician should reserve empirical therapy for critical 
patients, where time is inadequate for identification and 
isolation of the infection causing bacteria 
- prescribing is based on the clinicians working knowledge or 
experience of what is most likely to be the pathogen causing 
the patient’s condition 
 Prophylactic therapy: Antibiotic prophylaxis should be 
prescribed to susceptible patients to prevent specific 
infections that can cause definite detrimental effects. 
-The selection of an antibiotic for prophylaxis should be 
based on known or likely target pathogens, for a short 
duration of time. 
       Criteria for choosing an antibiotic drug: Antibiotic 
selection is vital to facilitate successful treatment of 
infections and minimize the development of antibiotic 
resistance. 
- Efficacy:  
1. Narrow spectrum or broad spectrum 
2. Monotherapy or combination therapy 
3. To achieve synergistic effect  
4. Combinational therapy also shortens the course of 
antibiotic therapy 
5. ILL patients require empirical therapy before 
bacteriological diagnosis 
6. To extend antibiotic spectrum during polymicrobial 
infections 
7. To prevent the development of bacterial resistance 
with long term therapy 
8. Efficacy at the site of infection & tissue penetration 
9. Bactericidal vs bacteriostatic therapy 
Dosage, Route of Administration and Duration:  
1. The clinician should consider pharmacokinetic and 
pharmacodynamic factors in determining the drug dose 
2. Oral/ enteral route of administration should be preferred 
in patients with mild-to-moderate infections 
Monitoring Response to Therapy: 
1. The need for an antimicrobial therapy should be reviewed 
on a daily basis by reviewing laboratory evidence 
2. Response to therapy depends on the nature and 
sensitivity of the agent, specificity of the drug, bioavailability 
and dosage 
3. Longer the doubling time of the organism, longer the time 
it takes to respond.[4,5] 
Antibiotic Resistance 
It is the situation which occurs when the microorganism is 
resistant to an antibiotic spectrum. These situation is due to 
changes in the genetic material of the micro oraganism, 
mutations in one (or)some of the gene (or)with a new  gene, 
by contamination of the organism. 
Factors Causing Resistance: 
1. Unneccesary antibiotic use 
2. Inproper use of antibiotics 
3. Incorrrect dosage intervals. 
Vaccines 
A vaccine is a biological preparation that provides active 
acquired immunity to a particular disease. 
A vaccine typically contains an agent that resembles a 
disease-causing microorganism and is often made from 
weakened or killed forms of the microbe, its toxins, or one of 
its surface proteins. 
Vaccines exit for the common influenza viruses ,measles, 
pertussis, the potentially invasive bacteria haemophilus 
influenza typeB and many serotypes of streptococcus 
pneumonia 
Influenza Vaccine:  
1) Inactivated /Trivalent vaccine-H1N1, H3N2, InfluenzaB 
2) Quadrivalent vaccine-H1N1, H3N2 and two strains of 
influenza B 
-As the season usually lasts between the months of Oct-
May,it is best to get the flu vaccine two week before these 
period as the body requires time to produce the necessary 
antibodies to fight the viruses. 
Vaccination schedule:-These vaccine can be administered 
after 6 months of age,2-4 weeks prior to the flu season:(2 
doses at the interval of 1month in the 1st year,and 1 dose 
annually before the flu season upto 5 years of age. 
Pertussis Vaccine: It protects against whooping cough. 
There are 2 types: 
1) Whole cell vaccine (78% effective) 
2) Acellular vaccines (71-85% effective) 
Vaccination schedule:-It has 3 primary doses at 6,10 and 14 
weeks and 2 boosters at 15-18 months and 5 years 
Pneumococcal Vaccine: It acts against the streptococcus 
pneumonia .it can prevent pneumonia, sepsis and meningitis 
There are 2 types: 
1) Conjugate vaccine 
2) Polysaccharide vaccine  
Vaccination schedule:- 3 doses at 6,10 and 14 weeks with a 
booster at 15 months 
Measles Vaccine: These vaccines prevent measles, that 
usually their effectiveness last for many years. 
They are: 
1) Standalone vaccine 
2)  MR Vaccine 
Hussaini et al                                                                                                             Journal of Drug Delivery & Therapeutics. 2020; 10(3):36-41 
ISSN: 2250-1177                                                                                  [38]                                                                                 CODEN (USA): JDDTAO 
 
 
3) MMR Vaccine 
4) MMRV Vaccine 
Vaccination schedule:-It is given under Universal 
Immunization Programme at 9-12 months of age and 2nd 
dose at 16-24 months of age. 
Haemophilus Influenza Type B Vaccine:-It is used to prevent 
haemophilus influenza type B infection. It is used to 
decrease in the rate of meningitis, pneumonia and 
epiglottitis. 
  Vaccination schedule:-It was given at 2,4,6 months and as a 
booster dose at 12-15 months 
Objectives: 
 To evaluate inappropriate antibiotic drug selection 
those are associated with increased drug resistance 
among respiratory pathogens. 
 Detailed information on commonly prescribed 
antibiotics for RTI.   
  To evaluate the problem of the increase in antibiotic 
resistance. 
METHODS AND METHODOLOGY: 
Inclusion Criteria Includes: 
 Children in P.I.C.U 
 Children in paediatric department suffering from 
respiratory tract infections 
 Children whose legal guardians are willing to give 
informed consent for the study 
 Children of age below 12 years are included. 
 Both genders are included. 
Exclusion Criteria: 
 Adults are excluded from the study 
 Geriatrics are excluded 
 Pregnant and lactating women are excluded. 
RESULTS 
Patient Population Demographics 
Table 1: Distribution of patients based on Gender 
Sex Patients Percentage 
Male 40 74 
Female 20 26 
Total 60 100 
 
 
Figure 1: Distribution of patients based on Gender
 
Table 2: Distribution of patients based on Age groups 
AGE(Yrs) 0-3 4-7 8-11 12-15 16-18  
MALE 26 5 7 1 0  
FEMALE 12 3 5 1 0  
 
 
Figure 2: Distribution of patients based on Age groups 
Table 3: Distribution of patients based on type of infection 
Age Group Sex 
LRTI URTI 
Pediatrics Male 31 8 
Female 16 5 
 Total 47 13 
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Figure 3.1: Distribution of patients with LRTI 
 
 
Figure 3.2: Distribution of patients with URTI 
 
 
Figure 3.3: Percentage of patients based on type of 
infection 
 
Table 4: Distribution of underlying co-morbidities in 
patients 
CO-MORBID DISEASES NO. OF PATIENTS 
Endocrine disorders 1 
Seizures 1 
Anemia 13 
Down syndrome 1 
None 44 
 
 
Figure.4: Distribution of underlying co-morbidities in 
patients 
 
 
Figure 5.1: Drugs prescribed in Males with LRTI 
 
 
Figure 5.2: Drugs prescribed in Males with URTI 
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Figure 5.3: Drugs prescribed in females with LRTI 
 
Figure 5.4: Drugs prescribed in Females with URTI
 
Table 5: Percentage utilization of different classes of Antibiotics in patients 
Antibiotics LRTI URTI TOTAL %Percentage 
Penicillin 33 4 37 55.22 
Cephalosporin 23 2 25 37.31 
Macrolide 2 0 2 2.98 
Aminoglycoside 3 0 3 4.47 
Total 61 6 67 100 
 
 
 
Figure 6: Percentage utilization of different classes of Antibiotics in patients 
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CONCLUSION 
RTI in children are one of the most common reasons for 
parents consulting health professionals.Most Respiratory 
tract infections are self limiting viral illnesses that will 
resolve with time and supportive management,but coming to 
bacterial infections there is an need for rational use of 
antibiotics.However,it is important for health professional to 
identify any RTI that may have more serious implications,for 
the child and require medical intention .[6,7] 
Sample population demographics: 
In this “A Prospective observational study on Rational use of 
antibiotics for paediatric in RTI ,”were evaluated in a total of 
60 patients.Among 60 patients,(74%) are males and (26%) 
are females.The total study populations were categorized in 
to 5 groups,depending up there age groups i.e,(0-3),(4-7),(8-
11),(12-15),(16-18) years.From the above categorized age 
groups ,age of (0-3) years mostly in males are infected,with 
Lower Respiratory Tract Infection.From the collected data it 
is known that most of the RTI patients are with Anaemia.The 
risk of Acute respiratory tract infection was due to iron 
deficiency anemia,as in which adequate iron is important for 
maturation of immune cells ,mainly lymphocytes .These 
lymphocytes helps in generation of specific response to 
infection.In these present study ,it is observed that patients 
with wheeze (or) crepts sounds,along cough with sputum 
have Shortness of breathe. 
Antibiotics utilization in Respiratory infections: 
In the present study it is observed that 4-different classes of 
antibiotics-Pencillins-[Augmentin, Tazobactum,  Piptaz], 
Cephalosporins –[Ceftriaxone, Monocef-O, Taxim, Cefixime, 
Cefoperaxone], Macrolides-[Azithromycin] and 
Aminoglycosides –[Amikacin] were prescribed and used for 
different Respiratory diseases.The percentage of average 
antibiotic utilization is highest in Lower Respiratory Tract 
Infection with (55.22%).Mostly used Antibiotic in males for 
both LRTI and URTI is Augmentin with the percentage of 
(52%) and (80%) respectively.Where as in females it is 
observed that in both LRTI and URTI mostly used Antibiotic 
is Augmentin with percentage of (38.8%) and( 80%) 
respectively.Overall Second mostly used antibiotic is 
Ceftriaxone. 
Treatment with antibiotics is neccessary for certain 
diseases,inorder to ensure survival,welfare,productivity, and 
to reduce spread of diseases.[10,11]The goal of rational use 
initiatives is not always to reduce antibiotic use,but instead 
ensure that the use is appropriate.Rational prescribing and 
rational drug use are important goals to achieve appropriate 
treatment to patients.[12,13] From the above prescribed drugs 
,some of the drugs are 1st line drugs that include 
Ceftriaxone(350mg), Augmentin(450mg), Monocef-O(50mg), 
Taxim(90mg), Amikacin(120mg) and Cefixime(2.5ml syrup). 
These drugs are considered as Rational Drugs i.e, 
appropriate medicines are prescribed in the correct dose and 
dosage form to the correct patient and at the lowest cost to 
the patient and the community.[8,9]. Due to the irrational use 
of drugs, there is an development of resistance to antibiotics, 
ineffective treatment, adverse effects, drug dependence 
which is an major problem in current medical practice. 
So,there is an urgent need to use mainly rational drugs to 
promote appropriate treatment to the children.[14] 
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